Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03965845
Title A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Calithera Biosciences, Inc

Advanced Solid Tumor

colorectal cancer

lung non-small cell carcinoma


Palbociclib + Telaglenastat

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.